StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.54+0.30 (+2.27%)

Close on Nov 16, 2026Market cap $250.17MP/E –Yield –

Earnings

USANA Health Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 17, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$206.00M
-3.7% on a year earlier
Adjusted diluted EPS (1), Q3 FY2026
-$0.11
-$0.15 a year earlier
Latest guidance
Lowered
Nov 3, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of USANA Health Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Jan 3, 2027Feb 17, 2027Expected–––––
Q3 FY2026ended Oct 3, 2026Nov 3, 2026after the close$206.00M-3.7%-$0.30-$0.11Release
Q2 FY2026ended Jul 4, 2026Aug 4, 2026after the close$223.00M-5.5%-$1.16-$0.07Release
Q1 FY2026ended Apr 4, 2026May 5, 2026after the close$250.00M0.0%$0.41$0.61Release
Q4 FY2025ended Jan 3, 2026Feb 18, 2026after the close$226.20M+5.7%-$0.10$0.60Release
Q3 FY2025ended Sep 27, 2025Oct 22, 2025after the close$214.00M+7.0%-$0.36-$0.15Release
Q2 FY2025ended Jun 28, 2025Jul 22, 2025after the close$236.00M+10.8%$0.52$0.74Release
Q1 FY2025ended Mar 29, 2025Apr 22, 2025after the close$250.00M+9.6%$0.49$0.73Release
Q4 FY2024ended Dec 28, 2024Feb 25, 2025after the close$214.00M-3.2%$0.23$0.64Release
Q3 FY2024ended Sep 28, 2024Oct 22, 2024after the close$200.00M-6.1%$0.56–Release
Q2 FY2024ended Jun 29, 2024Jul 23, 2024after the close$213.00M-10.5%$0.54–Release
Q1 FY2024ended Mar 30, 2024Apr 30, 2024after the close$228.00M-8.1%$0.86–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

USANA Health Sciences's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Consolidated net salesFY2026$900.00M–NewNov 3, 2026
Core Nutritional business net salesFY2026$750.00M$720.00M – $765.00MRaisedAug 4, 2026
Adjusted EBITDAnon-GAAPFY2026$87.00M$101.00M – $109.00MLoweredAug 4, 2026
Adjusted EBITDA (2)non-GAAPFY2026$77.00M$101.30M – $109.30MLoweredNov 3, 2026
Diluted EPSGAAPFY2026-$0.90$1.11 – $1.45LoweredNov 3, 2026
Diluted EPSGAAPFY2026-$0.61$1.11 – $1.45LoweredAug 4, 2026
Adjusted diluted EPSnon-GAAPFY2026$0.76$1.95 – $2.29LoweredAug 4, 2026
Adjusted diluted EPS(1)non-GAAPFY2026$0.55$1.95 – $2.29LoweredNov 3, 2026
Net (loss) earningsGAAPFY2026-$16.00M–LoweredNov 3, 2026
Net (loss) earningsGAAPFY2026-$11.00M–LoweredAug 4, 2026
Net earningsGAAPFY2026$20.00M – $27.00M–NewMay 5, 2026
Net earningsGAAPFY2026$20.30M – $26.60M–NewFeb 18, 2026

Guidance history

Every forecast USANA Health Sciences put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026Adjusted EBITDA (2)FY2026$77.00MLowered
Nov 3, 2026Adjusted diluted EPS(1)FY2026$0.55Lowered
Nov 3, 2026Diluted EPSFY2026-$0.90Lowered
Nov 3, 2026Net (loss) earningsFY2026-$16.00MLowered
Nov 3, 2026Consolidated net salesFY2026$900.00MNew
Aug 4, 2026Adjusted EBITDAFY2026$87.00MLowered
Aug 4, 2026Adjusted diluted EPSFY2026$0.76Lowered
Aug 4, 2026Diluted EPSFY2026-$0.61Lowered
Aug 4, 2026Net (loss) earningsFY2026-$11.00MLowered
Aug 4, 2026Core Nutritional business net salesFY2026$750.00MRaised
Aug 4, 2026Hiya net salesFY2026$125.00MLowered
Aug 4, 2026Rise Wellness net salesFY2026$35.00MLowered
Aug 4, 2026Consolidated net salesFY2026$910.00MRaised
May 5, 2026Adjusted EBITDAFY2026$101.00M – $109.00MNew
May 5, 2026Adjusted diluted EPSFY2026$1.95 – $2.29New
May 5, 2026Diluted EPSFY2026$1.11 – $1.45New
May 5, 2026Net earningsFY2026$20.00M – $27.00MNew
May 5, 2026Core Nutritional business net salesFY2026$720.00M – $765.00MNew
May 5, 2026Hiya net salesFY2026$140.00M – $155.00MLowered
May 5, 2026Rise Wellness net salesFY2026$65.00M – $80.00MLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases USANA Health Sciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Update
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?